DiaMonTech unveils non-invasive method for measuring blood glucose levels

By Jonathan Dyble
German healthcare firm DiaMonTech has unveiled a new breakthrough technology with its non-invasive method for measuring the body’s blood glucose level...

German healthcare firm DiaMonTech has unveiled a new breakthrough technology with its non-invasive method for measuring the body’s blood glucose levels.

In a timely manner, the new announcement was made on world diabetes day – a condition that will be revolutionised by the new technology by removing the need for finger pricking in order to measure glucose levels.

See also:

“With 400 million people suffering from diabetes worldwide, this new device will liberate many from the antiquated means of pricking their fingers and the potential health risks it carries,” DiaMonTech said.

DiaMonTech’s Head of Research and Development and Director of the Biophysics Institute at Goethe University, Professor Werner Mäntele, was behind its development – a man who specialises in spectroscopy and molecule detection.

“Unlike previous diabetic monitoring methods, which have focused on one particular layer of the skin to measure blood glucose, DiaMonTech’s approach means blood glucose is measured with ‘depth-profiling’,” Mäntele said.

“This method allows us to measure one’s skin at a multitude of different depths and is fine-tuned to measure glucose molecules rather than a high-level overview.” 

A DiaMonTech desktop device is scheduled for release in 2018, with smaller pocket-sized devices to come in 2019 and a smart-wristband that constantly monitors glucose levels expected in 2021.

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability